ACXP · Categories · Form 4

ACXP - SEC Form 4 insider transactions

Acurx Pharmaceuticals Inc. (ACXP) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for ACXP

• 4d
  SEC Form 4 filed by Sailer Carl

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 4d
  SEC Form 4 filed by Dean Jack H

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 4d
  SEC Form 4 filed by Donohue James J.

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 4d
  SEC Form 4 filed by Harrison Thomas L

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 4d
  SEC Form 4 filed by Scodari Joseph C

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 4d
  SEC Form 4 filed by Deluccia Robert J

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 4d
  SEC Form 4 filed by Luci David P

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 4d
  SEC Form 4 filed by Shawah Robert G.

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 444d
  SEC Form 4 filed by Chief Financial Officer Shawah Robert G.

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 444d
  SEC Form 4 filed by President and CEO Luci David P

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 444d
  SEC Form 4 filed by Director Deluccia Robert J

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 677d
  SEC Form 4 filed by Director Scodari Joseph C

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 677d
  SEC Form 4 filed by Director Sailer Carl

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 677d
  SEC Form 4 filed by Director Harrison Thomas L

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 677d
  SEC Form 4 filed by Director Donohue James J.

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 677d
  SEC Form 4 filed by Director Dean Jack H

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 753d
  SEC Form 4 filed by Shawah Robert G.

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 753d
  SEC Form 4 filed by Luci David P

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 753d
  SEC Form 4 filed by Deluccia Robert J

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 825d
  Sailer Carl exercised 19,737 shares at a strike of $3.55, increasing direct ownership by 21% to 112,552 units (SEC Form 4)

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 843d
  Deluccia Robert J gifted 110,000 shares and exercised 19,737 shares at a strike of $3.55, decreasing direct ownership by 9% to 960,935 units (SEC Form 4)

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 843d
  Luci David P exercised 19,737 shares at a strike of $3.55, increasing direct ownership by 2% to 1,048,197 units (SEC Form 4)

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1045d
  SEC Form 4 filed by Donohue James J.

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1045d
  SEC Form 4 filed by Harrison Thomas L

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1045d
  SEC Form 4 filed by Sailer Carl

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1045d
  SEC Form 4 filed by Dean Jack H

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1045d
  SEC Form 4 filed by Scodari Joseph C

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1157d
  SEC Form 4 filed by Luci David P

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1157d
  SEC Form 4 filed by Shawah Robert G.

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1157d
  SEC Form 4 filed by Deluccia Robert J

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1367d
  SEC Form 4: Sailer Carl bought $75,001 worth of shares (19,737 units at $3.80), increasing direct ownership by 27% to 92,815 units

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1367d
  SEC Form 4: Deluccia Robert J bought $75,001 worth of shares (19,737 units at $3.80), increasing direct ownership by 2% to 1,051,198 units

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1367d
  SEC Form 4: Luci David P bought $75,001 worth of shares (19,737 units at $3.80), increasing direct ownership by 2% to 1,028,460 units

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1614d
  SEC Form 4: Sailer Carl bought $24,979 worth of shares (5,161 units at $4.84), increasing direct ownership by 8% to 73,078 units

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1616d
  SEC Form 4: Deluccia Robert J bought $24,672 worth of shares (5,034 units at $4.90), increasing direct ownership by 0.49% to 1,031,461 units

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1616d
  SEC Form 4: Luci David P bought $24,960 worth of shares (5,200 units at $4.80), increasing direct ownership by 0.52% to 1,008,723 units

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)
• 1689d
  SEC Form 4: Sailer Carl bought $75,000 worth of Common Stock (12,500 units at $6.00), increasing direct ownership by 23% to 67,917 units

  4 - Acurx Pharmaceuticals, Inc. (0001736243) (Issuer)

Other ACXP categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends